In addition, miR‐23a‐3p functioned as tumour oncogene in renal cell carcinoma, and miR‐23a‐3p silence inhibited the proliferation and mobility in RCC cells by targeting PNRC2.41 This evidence concerns the gene PNRC2 and renal cell carcinoma.